AID-TAT peptide

a cardioprotective agent that corresponds to α1‐beta nteraction domain in the I‐II linker of the L-type calcium channel

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Reperfusion Injury 06/23/2014 - "Treatment with AID-TAT peptide decreased ischemia-reperfusion injury in guinea-pig hearts ex vivo (n=11) and in rats in vivo (n=9) assessed with uptake of nitroblue tetrazolium, release of creatine kinase, and lactate dehydrogenase. "
2.	Infarction (Infarctions) 06/23/2014 - "Application of AID-TAT peptide significantly decreased infarct size and supported contractility up to 12 weeks postcoronary artery occlusion as a result of a decrease in metabolic demand during reperfusion."

1.	Nitroblue Tetrazolium
2.	L-Lactate Dehydrogenase (Lactate Dehydrogenase)
3.	Creatine Kinase (Creatine Phosphokinase)